(LifeSiteNews) – Twenty left-wing attorneys general have banded together to declare that abortion pills are safe in response to a federal data review that could lead to new restrictions on the controversial drug.
“For more than 25 years, mifepristone has been used safely and effectively in the United States and globally. It is currently the most common method for early-term abortion care in the United States and is the standard of care for managing early miscarriage,” the statement says. “The decision to reexamine access to this medication was made in response to a scientifically baseless letter and ignores decades of research that proves mifepristone is safe and effective. Medical decisions should be left between patients, their families, and their providers — and they should be guided by science, not political agendas.
“As state attorneys general, we have a responsibility to enforce state laws and protect our residents, including their access to reproductive care. If access to mifepristone is challenged, we will take action to protect it,” concluded the group, composed of the top law enforcement officials from Arizona, California, Colorado, Connecticut, Delaware, the District of Columbia, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont, and Washington state.
In fact, for years evidence has indicated the opposite. A 2020 open letter from a coalition of pro-life groups to then-U.S. Food & Drug Administration (FDA) Commissioner Stephen Hahn noted that the FDA’s own adverse reporting system says the “abortion pill has resulted in over 4,000 reported adverse events since 2000, including 24 maternal deaths. Adverse events are notoriously underreported to the FDA, and as of 2016, the FDA only requires abortion pill manufacturers to report maternal deaths.” A May 2025 Charlotte Lozier Institute study also found that most emergency room visits stemming from abortion pill complications are misattributed to miscarriages, further making the pills appear safer than they really are.
“A November 2021 study by Charlotte Lozier Institute scholars appeared in the peer-reviewed journal Health Services Research and Managerial Epidemiology,” Catholic University of America research associate Michael New wr0te. “They analyzed state Medicaid data of over 400,000 abortions from 17 states that fund elective abortions through their Medicaid programs. They found that the rate of abortion-pill-related emergency-room visits increased over 500 percent from 2002 through 2015. The rate of emergency-room visits for surgical abortions also increased during the same time period, but by a much smaller margin.’”
The FDA under the Trump administration is currently conducting a review of the safety data behind mifepristone, which Health & Human Services (HHS) Secretary Robert F. Kennedy Jr. says has already found evidence that the data was “twisted” in the abortion drug’s favor.
That position was complicated recently when the FDA approved a new generic version of the abortion pill; HHS later indicated the approval was a technicality required by law and will not affect the final verdict on all forms of mifepristone.
The matter carries great urgency in light of the fact that unregulated, no-oversight distribution of abortion pills across state lines has become arguably the abortion lobby’s most effective tactic for circumventing state pro-life laws, as pills can be mailed, received, and taken in complete privacy, without any sign law enforcement can act on.
